Bristol-Myers Squibb

Bristol-Myers beats Street 2Q forecasts
Yahoo/AP
Thu, 07/28/16 - 09:11 am
Bristol-Myers Squibb
earnings
J&J joins the combo lineup at Bristol-Myers, where a new wagon master runs oncology R&D
Endpoints
Tue, 07/26/16 - 11:11 am
JNJ
Bristol-Myers Squibb
R&D
Bristol-Myers Squibb Co (BMY) Q2 Earnings: What To Expect
Bidness, ETC
Mon, 07/25/16 - 06:28 pm
Bristol-Myers Squibb
earnings
AbbVie and Bristol-Myers Squibb to collaborate on lung cancer clinical trial
Marketwatch
Mon, 07/25/16 - 10:55 am
AbbVie
Bristol-Myers Squibb
lung cancer
clinical trials
Rova-T
Opdivo
Bristol-Myers settles for $30 million over California kickback claims
BioPharma Dive
Tue, 07/19/16 - 10:29 pm
Bristol-Myers Squibb
kickbacks
California
Bristol-Myers Squibb Reveals Regulatory Approvals For Opdivo Marketing Application
Yahoo/Benzinga
Mon, 07/18/16 - 11:07 am
Bristol-Myers Squibb
Opdivo
squamous cell carcinoma of the head and neck
FDA
EMA
Which big biopharma companies put R&D as their top priority?
Endpoints
Mon, 07/18/16 - 09:46 am
R&D
AstraZeneca
Eli Lilly
Celgene
Bristol-Myers Squibb
The 15 top R&D spenders in the global biopharma business
Endpoints
Fri, 07/15/16 - 10:23 am
R&D
Roche
JNJ
Novartis
Pfizer
Merck
Bristol-Myers Squibb
Here's How Pfizer's Protecting Its Kidney Cancer Drug From New Competitors
Motley Fool
Sun, 07/10/16 - 11:59 am
Pfizer
Sutent
kidney cancer
Exelixis
Bristol-Myers Squibb
Novartis
Bristol-Myers buys Swedish company with immunotherapy treatment
Marketwatch
Tue, 07/5/16 - 11:44 am
Bristol-Myers Squibb
M&A
Sweden
immunotherapy
Cormorant
HuMax-IL8
UK cost agency rejects Bristol's Opdivo for kidney cancer
Yahoo/Reuters
Tue, 07/5/16 - 10:23 am
UK
Bristol-Myers Squibb
Opdivo
kidney cancer
NICE
Bristol-Myers Squibb Co Wins a Sixth Breakthrough Tag for Opdivo
Bidness, ETC
Tue, 06/28/16 - 05:23 pm
Bristol-Myers Squibb
Opdivo
breakthrough therapies
bladder cancer
FDA
Bristol-Myers Squibb's bladder cancer treatment granted breakthrough therapy designation
Marketwatch
Mon, 06/27/16 - 10:28 am
Bristol-Myers Squibb
bladder cancer
breakthrough therapies
FDA
Opdivo
3 Ways This $30 Billion Market Is Bristol's for the Taking
Motley Fool
Tue, 06/21/16 - 11:16 pm
Bristol-Myers Squibb
immuno-oncology
Opdivo
Can Bristol-Myers Continue To Post Double-Digit Earnings Beats?
Seeking Alpha
Mon, 06/20/16 - 10:16 am
Bristol-Myers Squibb
Will Merck & Co Keytruda Surpass Bristol-Myers Opdivo In Immunotherapies Race?
Bidness, ETC
Fri, 06/17/16 - 10:17 am
Merck
Bristol-Myers Squibb
Keytruda
Opdivo
cancer immunotherapy
Pfizer, Novartis, BMS join $45M round for early fibrotic disease startup
Fierce Biotech
Fri, 06/17/16 - 09:56 am
Pfizer
Novartis
Bristol-Myers Squibb
fibrotic disease
U.S. regulator says too many drugmakers chasing same cancer strategy
Yahoo/Reuters
Fri, 06/10/16 - 08:53 am
FDA
oncology
ASCO 2016
Merck
Bristol-Myers Squibb
PD-1 inhibitors
Bristol-Myers And MD Anderson Cancer Center Makes Fresh Research Alliance In Immuno-Oncology Focused On Lung-Cancer
Yahoo/Benzinga
Wed, 06/8/16 - 09:35 am
Bristol-Myers Squibb
MD Anderson Cancer Center
R&D
immuno-oncology
Bristol-Myers Squibb Promises To Publish Failed Study After Long Delay
Forbes
Mon, 06/6/16 - 11:04 pm
Bristol-Myers Squibb
Yervoy
clinical trials
prostate cancer

Pages